A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing

Betta Clinical Study Site 25, Beijing

Betta Clinical Study Site 34, Shenyang

Betta Clinical Study Site 17, Shenyang

Betta Clinical Study Site 7, Dalian

Betta Clinical Study Site 16, Changchun

Betta Clinical Study Site 15, Changchun

Betta Clinical Study Site 40, Harbin

Betta Clinical Study Site 21, Nanjing

Betta Clinical Study Site 8, Nanjing

Betta Clinical Study Site 2, Hefei

Betta Clinical Study Site 3, Hefei

Betta Clinical Study Site 4, Bengbu

Betta Clinical Study Site 27, Wuhu

Betta Clinical Study Site 26, Tianjin

Betta Clinical Study Site 37, Tianjin

Betta Clinical Study Site 33, Hangzhou

Betta Clinical Study Site 19, Nanchang

Betta Clinical Study Site 20, Nanchang

Betta Clinical Study Site 24, Shangrao

Betta Clinical Study Site 38, Ganzhou

Betta Clinical Study Site 9, Fuzhou

Betta Clinical Study Site 22, Xiamen

Betta Clinical Study Site 42, Chongqing

Betta Clinical Study Site 36, Changsha

Betta Clinical Study Site 35, Changsha

Betta Clinical Study Site 13, Changsha

Betta Clinical Study Site 6, Changde

Betta Clinical Study Site 43, Wuhan

Betta Clinical Study Site 28, Wuhan

Betta Clinical Study Site 12, Wuhan

Betta Clinical Study Site 29, Wuhan

Betta Clinical Study Site 31, Xiangyang

Betta Clinical Study Site 18, Meizhou

Betta Clinical Study Site 14, Huizhou

Betta Clinical Study Site 10, Zhanjiang

Betta Clinical Study Site 11, Nanning

Betta Clinical Study Site 30, Xi'an

Betta Clinical Study Site 41, Lanzhou

Betta Clinical Study Site 39, Lanzhou

Betta Clinical Study Site 32, Ürümqi

Betta Clinical Study Site 5, Cangzhou

Betta Clinical Study Site 23, Taiyuan